{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:29:25Z","timestamp":1793478565399,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012546","name":"Chongqing Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-BHX0115"],"award-info":[{"award-number":["CSTB2023NSCQ-BHX0115"]}],"id":[{"id":"10.13039\/100012546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pnpbp.2026.111963","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:19:11Z","timestamp":1791587951000},"page":"111963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of the efficacy and safety of lacosamide and oxcarbazepine monotherapy in young children aged 1\u202fmonth to 4\u202fyears with focal epilepsy: An ambispective cohort study based on real-world clinical practice in China"],"prefix":"10.1016","volume":"150","author":[{"given":"Miao","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111963_bb0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40263-013-0048-z","article-title":"Pharmacotherapy of focal epilepsy in children: a systematic review of approved agents","volume":"27","author":"Arya","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"16","author":"Baulac","year":"2017","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0015","first-page":"CD012433","article-title":"Oxcarbazepine add-on for drug-resistant focal epilepsy","volume":"3","author":"Bresnahan","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-016-0406-8","article-title":"Tolerability and safety of commonly used antiepileptic drugs in adolescents and adults: a clinician's overview","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8110456","article-title":"The phenotypic spectrum of PRRT2-associated paroxysmal neurologic disorders in childhood","volume":"8","author":"D\u00f6ring","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0030","article-title":"Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy","volume":"21","author":"Driessen","year":"2023","journal-title":"Epilepsy Behav. Rep."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/epd2.20072","article-title":"Peri-ictal EEG in infants with PRRT2-related self-limited infantile epilepsy","volume":"25","author":"Fearn","year":"2023","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2147\/NDT.S452784","article-title":"Clinical analysis of Lacosamide monotherapy in the treatment of self-limited epilepsy with Centrotemporal spikes","volume":"20","author":"Feng","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0045","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00415-009-5157-8","article-title":"Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy","volume":"256","author":"Franzoni","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0050","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/epi.17366","article-title":"Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years","volume":"63","author":"French","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0055","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/brain\/awy051","article-title":"PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2\/1.6 activity","volume":"141","author":"Fruscione","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.braindev.2020.04.009","article-title":"Lacosamide for children with paroxysmal kinesigenic dyskinesia","volume":"42","author":"Furukawa","year":"2020","journal-title":"Brain Dev"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000366","article-title":"Quantifying the impact of unmeasured confounding in observational studies with the E value","volume":"2","author":"Gaster","year":"2023","journal-title":"Bmjmed"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.826897","article-title":"Case report: a case of concomitant paroxysmal Kinesigenic dyskinesia and epilepsy: can we treat two birds with one stone?","volume":"13","author":"Geng","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-1211(97)00025-9","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy","volume":"27","author":"Guerreiro","year":"1997","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0090","first-page":"1611","article-title":"Effectiveness of Lacosamide on everyday cognitive deficits, psychiatric symptoms and resilience in patients with epilepsy","volume":"70","author":"Gul","year":"2020","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0095","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40263-018-0523-7","article-title":"Lacosamide: a review in focal-onset seizures in patients with epilepsy","volume":"32","author":"Hoy","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.seizure.2018.06.013","article-title":"Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: an observational study","volume":"60","author":"Hur","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106408","article-title":"Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: an observational study in the real world","volume":"166","author":"Li","year":"2020","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.112450","article-title":"Association of both prenatal and early childhood multiple metals exposure with neurodevelopment in infant: a prospective cohort study","volume":"205","author":"Liu","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/add.12714","article-title":"A \u2018missing not at random\u2019 (MNAR) and \u2018missing at random\u2019 (MAR) growth model comparison with a buprenorphine\/naloxone clinical trial","volume":"110","author":"McPherson","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0125","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cpt.2681","article-title":"Extrapolation of efficacy from adults to pediatric patients of drugs for treatment of partial onset seizures: a regulatory perspective","volume":"112","author":"Mehrotra","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2018.04.015","article-title":"Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting","volume":"58","author":"Meschede","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0135","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0140","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/WNL.0b013e3182635b87","article-title":"Development and validation of the pediatric epilepsy side effects questionnaire","volume":"79","author":"Morita","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0145","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200018","article-title":"Clinical characteristics of seizures and epilepsy in individuals with recurrent deletions and duplications in the 16p11.2 region","volume":"8","author":"Moufawad El Achkar","year":"2022","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0150","series-title":"Drug approval certificate delivery information on may 17, 2023","author":"National Medical Products Administration","year":"2023"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0155","series-title":"Drug approval certificate delivery information on January 29, 2024","author":"National Medical Products Administration","year":"2024"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0160","series-title":"Drug approval certificate delivery information on October 14, 2024","author":"National Medical Products Administration","year":"2024"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.seizure.2023.06.004","article-title":"Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to <12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis","volume":"110","author":"Omatsu","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12887-019-1798-7","article-title":"Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine","volume":"19","author":"Pan","year":"2019","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0175","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1474-4422(23)00151-5","article-title":"Drug resistance in epilepsy","volume":"22","author":"Perucca","year":"2023","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the clinical genome resource (ClinGen)","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0185","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/epi.17843","article-title":"A real-world comparison among third-generation antiseizure medications: results from the COMPARE study","volume":"65","author":"Roberti","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jpc.14156","article-title":"Lacosamide in children with drug-resistant epilepsy","volume":"55","author":"R\u00fcegger","year":"2019","journal-title":"J Paediatrics Child Health"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0195","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/cpt.2694","article-title":"Effects of Mexiletine and Lacosamide on nerve excitability in healthy subjects: a randomized, double-blind, placebo-controlled, crossover study","volume":"112","author":"Ruijs","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0200","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107880","article-title":"Short- and long-term outcomes of immediate and delayed treatment in epilepsy diagnosed after one or multiple seizures","volume":"117","author":"Sharma","year":"2021","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pediatrneurol.2023.09.021","article-title":"Lacosamide for the treatment of seizures in neonates and infants: a retrospective assessment of efficacy and tolerability","volume":"149","author":"Shoaib","year":"2023","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0215","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0000000000011839","article-title":"Incidence and prevalence of drug-resistant epilepsy: a systematic review and Meta-analysis","volume":"96","author":"Sultana","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0225","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1111\/epi.18098","article-title":"Optimizing ketogenic diet therapy for childhood epilepsy: identifying key factors for seizure control and psychomotor enhancement","volume":"65","author":"Tong","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejmg.2018.08.002","article-title":"PRRT2-related phenotypes in patients with a 16p11.2 deletion","volume":"62","author":"Vlaskamp","year":"2019","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0240","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jnnp-2020-323524","article-title":"Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial","volume":"91","author":"Vossler","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0235","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/epi.13502","article-title":"Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: results from a multicenter, open-label trial","volume":"57","author":"Vossler","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109227","article-title":"Investigation of the efficacy and adverse effects of lacosamide over 36 months","volume":"144","author":"Wakabayashi","year":"2023","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0250","first-page":"339","article-title":"Analysis of clinical and genetic characteristics of epilepsy associated with chromosome 16p11.2 microdeletion","volume":"60","author":"Wang","year":"2022","journal-title":"Chin. J. Pediatr."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0255","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2165\/00002018-200528110-00006","article-title":"Detecting treatment emergent adverse events in clinical trials: a comparison of spontaneously reported and solicited collection methods","volume":"28","author":"Wernicke","year":"2005","journal-title":"Drug Saf."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.seizure.2024.04.009","article-title":"Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: results from a prospective cohort study in China","volume":"118","author":"Xiong","year":"2024","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2026.111963_bb0265","article-title":"Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0270","article-title":"Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy","volume":"14","author":"Yi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0275","article-title":"Effectiveness and safety of oxcarbazepine vs. Levetiracetam as monotherapy for infantile focal epilepsy: a longitudinal cohort study","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111963_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2023.01.018","article-title":"Twelve-month efficacy of Lacosamide monotherapy at maximal dose and tolerability for epilepsy treatment in pediatric patients: real-world clinical experience","volume":"142","author":"Zhao","year":"2023","journal-title":"Pediatr. Neurol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626003611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626003611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:37:00Z","timestamp":1793475420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626003611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":55,"alternative-id":["S0278584626003611"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111963","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the efficacy and safety of lacosamide and oxcarbazepine monotherapy in young children aged 1\u202fmonth to 4\u202fyears with focal epilepsy: An ambispective cohort study based on real-world clinical practice in China","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111963"}}